Pozdrav svima... Ukratko iznecu svoje iskustvo sa Vitiligom koji imam vec petnaestak godina... Dugo vremena nisam pokusavao nista da ucinim jer sam od lekara opšte prakse dobio informaciju da se vitiligo ne leci, a imao sam bele pecate na mestima koje se inace ne vide... Medjutim, od pre par godina pojavile su se depigmentirani delovi na licu i po prstima, tako da sam poceo da tražim način da to saniram...
Prošle godine sam oko šest meseci koristio Vitix krem i tablete u kombinaciji sa vitaminom B12 (u Bgdu sam našao neke američke tablete Neuro B12 complex, prilično skupe) i sve to sa sunčanjem tokom leta... Primetio sam blaga poboljšanja na licu ali vrlo slaba... Uz to Vitix krem izaziva zatamljenja pigmentovanog oboda kože oko svetlih delova što samo pogoršava estetsko stanje kože, ali primetio sam pojave pigmentovanih pega po svetlim delovima posebno u vreme intezivnog sunčanja...
Od pre dva i po meseca koristim krem Elidel (pimecrolimus 0.1%) inače krema namenjena za lečenje ekcema (može se povoljno naći u Beogradu) , uz sunčanje sa zaštitnim kremama i povremeno korišćenje vitamina B12, ali i Tana (susamovog butera) koji prirodno obiluje vitaminima B grupe... U odnosu na Vitix krem, rezultati su spektakularni... na licu (oko očiju) svetla koža je prirodno počela da tamni, a raniji tamni pečati da se šire... Na žalost, na rukama su rezultati manje primetni...
Treba reći, da je Elidel navodno zamena za Protopic 01%, trebalo bi da slično deluje i namenjen je za lečenje ekcema... takođe u uputstvu piše da treba izbegavati sunčanje jer je fotosenzitivan, što ja baš i nisam poštovao, naprotiv... Moje iskustvo je da bez sunca nemam previše rezultata... Verovatno da i UV lampa pomaže zimi kao zamena za sunčanje...
Uz ovu kremu nameravam da probam i kremu Placental koja se pravi u Zemunu... Ona bi trebalo da prehranjuje ćelije kože i pomaže repigmentaciju...
Nadam se da razmena iskustava može drugima pomoći, jer sam se i ja tako uputio, srećom sa nekim pozitivnim rezultatima... Na žalost, radi se o takvoj bolesti za koju dermatolozi nemaju pouzdana rešenja, a različiti tretmani lečenja kod različitih osoba daju različite rezultate...
A evo, izmedju ostalog, sta kaže Wikipedija i reference sa nje:
Studies have also shown that immunomodulator creams such as Protopic and Elidel also cause repigmentation in some cases, when used with UVB Narrowband treatments.[10][11]
Reference:
10)
Kwinter J, Pelletier J, Khambalia A, Pope E (2007). "High-potency steroid use in children with vitiligo: a retrospective study". J. Am. Acad. Dermatol. 56 (2): 236–41
Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo: results of a prospective patient series.Tanghetti EA.
Center for Dermatology and Laser Surgery, Sacramento, California, USA.
et@mgci.com
The cause of the selective melanocyte destruction in vitiligo may be due to an autoimmune disorder. A series of 15 patients with vitiligo were treated with a topical immunomodulator, tacrolimus ointment 0.1%, twice daily for a minimum of 45 days. Thirteen patients (87%) experienced at least partial repigmentation, and 3 of those patients had greater than 75% repigmentation. Patients with the greatest treatment response likely benefited from concomitant natural sunlight exposure. Further studies investigating the safety and efficacy of tacrolimus ointment either as monotherapy or in combination with other therapeutic measures are warranted.
11)
Silverberg NB, Lin P, Travis L, Farley-Li J, Mancini AJ, Wagner AM, Chamlin SL, Paller AS.
Department of Dermatology, Division of Pediatric Dermatology, St Luke's-Roosevelt Hospital Center, New York, NY, USA.
BACKGROUND: Vitiligo is an autoimmune disorder characterized by loss of pigmentation. Phototherapy and application of topical corticosteroids are most commonly prescribed. However, these therapies are often not effective and use of corticosteroids on the face may lead to cutaneous atrophy, telangiectasia, and ocular complications. OBJECTIVE: We sought to assess the efficacy of topical tacrolimus ointment in the treatment of pediatric vitiligo. METHODS: A retrospective review was performed of 57 pediatric patients with vitiligo at two clinical sites. Patients were treated with tacrolimus ointment for at least 3 months. Clinical responses were documented during clinic visits, and by pretacrolimus and posttacrolimus photography. RESULTS: At least partial response was noted to tacrolimus ointment on the head and neck in 89%, and on the trunk and extremities in 63% of patients. Facial vitiligo of the segmental type showed the best response rate. Two patients initially experienced burning on application. CONCLUSIONS: Topical tacrolimus ointment is an effective alternative therapy for childhood vitiligo, particularly involving the head and neck.